InvestorsHub Logo
Followers 19
Posts 3820
Boards Moderated 0
Alias Born 09/23/2014

Re: None

Thursday, 07/15/2021 4:18:26 PM

Thursday, July 15, 2021 4:18:26 PM

Post# of 140474
Titan is developing an endoluminal prototype w Titan IP in it.

Reminder for anyone not paying attention: in order for anyone to compete w ISRG they will need multi port, single port and endoluminal. So what does Medtronic have, they have a multi port system called Hugo, they will need an endoluminal system (we will call this milestone 4 prototype) and they will need a single port system (Enos)

Auris (endoluminal - one indication) went for $5.7B. The software science project vicarious w NO PATENT PROTECTION is a POS knock off single port system valued at $1.1B (btw it’s single indication is hernias). ISRG SP - single indication - has added over $8B in MC to ISRG.

IT is very easy to get to a multi billion dollar valuation w Titan considering they will deliver an endoluminal prototype w Titan IP, they have a next generation surgical robotic single port system, their IP will enhance second generation HUGO SYSTEM, they have a world class R&D team and one of the best IP portfolios in the surgical robotic space.